Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02663908
Title A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Ferring Pharmaceuticals
Indications

prostate cancer

Therapies

Degarelix

Leuprolide

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.